INIS
enzymes
90%
diseases
74%
sulfates
60%
therapy
57%
humans
50%
production
39%
storage
35%
proteins
34%
mutations
32%
genes
31%
gene therapy
27%
in vitro
26%
patients
25%
accumulation
24%
fibroblasts
23%
vectors
22%
evaluation
20%
tools
19%
metabolism
18%
yeasts
17%
bones
16%
design
16%
biology
15%
colombia
15%
substrates
14%
central nervous system
14%
mice
14%
chondroitin
13%
lysosomes
12%
comparative evaluations
12%
enzyme activity
12%
levels
11%
bacteria
11%
stability
10%
lipids
10%
reduction
10%
interactions
10%
errors
10%
reviews
10%
antibodies
9%
transport
9%
ph value
9%
assessments
9%
applications
9%
growth
9%
bioreactors
9%
promoters
8%
modeling
8%
glycoproteins
8%
peptides
8%
delivery
8%
information
7%
amino acids
7%
signals
7%
bovine
7%
strains
7%
cavities
7%
brain
7%
viruses
6%
genetics
6%
cartilage
6%
tissues
6%
construction
6%
nervous system diseases
6%
nanoparticles
6%
fungi
6%
host
6%
prediction
5%
food
5%
damage
5%
affinity
5%
apoptosis
5%
vaccines
5%
distribution
5%
concentration
5%
molecules
5%
yields
5%
oxidation
5%
in vivo
5%
stem cells
5%
balances
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mucopolysaccharidosis
100%
Replacement Therapy
49%
Diseases
48%
Sulfatase
48%
Sulfate
45%
N Acetylgalactosamine
44%
Lysosome Storage Disease
33%
Glycosaminoglycan
29%
Recombinant
24%
Keratan Sulfate
22%
Escherichia coli
22%
Komagataella pastoris
21%
Pharmacological Chaperone
16%
Chondroitin 6 Sulfate
16%
Syndrome
15%
Recombinant Enzyme
14%
Lysosome Enzyme
13%
Storage Disease
12%
Inborn Error of Metabolism
12%
Laccase
11%
Amino Acid
10%
Microorganism
9%
Komagataella
9%
Fibrinogen
9%
Fructose Oligosaccharide
7%
Lactobacillus plantarum
7%
Nanoparticle
7%
Bone Dysplasia
7%
Transcription Factors
7%
Clinical Feature
6%
Signal Peptide
6%
Blood-Brain Barrier
6%
Complementary DNA
5%
Morquio Syndrome
5%
Autosomal Recessive Disorder
5%
Gene Delivery
5%
Pranlukast
5%
GM2 Gangliosidoses
5%
Tay Sachs Disease
5%
Methylotrophic Yeast
5%
Beta N Acetylhexosaminidase A
5%